Background:
Urinary tract infection (UTI) is a major health concern worldwide. The present study was aimed to compare drug resistance to ceftriaxone and cefazolin in adult patients with acute pyelonephritis.
Archives of Clinical Infectious Diseases
Urinary tract infection (UTI) is a major health concern worldwide. The present study was aimed to compare drug resistance to ceftriaxone and cefazolin in adult patients with acute pyelonephritis.
For this clinical trial, patients with fever plus either dysuria, frequency, flank pain or flank tenderness were enrolled. Having performed urinalysis (U/A), urine culture (U/C) and antibiogram, they were randomly assigned in two groups: ceftriaxone 1gr twice a day or cefazolin 1gr trice a day. Three days later, urine was re-evaluated and patients were categorized as clinical and microbiological responders. Chi-square test and Fishers exact tests were used, when appropriate. Statistical significance was defined as p<0.05.
Study population included 59 females and 27 males. Escherichia coli was the most frequent isolated pathogen (86.0%). Dysuria, flank pain and flank tenderness was more frequent among non-E. coli-infected than E. coli-infected subjects, however, the difference was solely significant for flank tenderness (p=0.008). Clinical response was observed in 86.1%, 11.6%, and 2.3% of patients 3, 4, and 5 days following the therapy, respectively, however, there was no significant difference between ceftriaxone and cefazolin group. Totally, 93% of patients became culture negative. Rate of microbiological response did not differ significantly between groups.
The results demonstrated that clinical and microbiological responses of patients with acute pyelonephritis are not always compatible. Meanwhile, first and third generation cephalosporins have similar efficacy for treatment of uncomplicated patients.
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Ziae H, Mosavi S, Ghorbani R. Comparison of efficacy of oral ciprofloxacin versus IV eftriaxone in acute uncomplicated pyelonephritis. koomesh. 2002;4(1):e151969. doi:
Falahatkar S, Mokhtari G, Kazemnezhad Leyli E, Abed-Kamalchi M, Kazemi S, et al. The Impact of Antibiotic Prophylaxis with Cefazolin, and Ceftizoxime Along with Aminoglycosides on Postoperative Complications, Hospitalization, and Returning to Normal Life for Percutaneous Nephrolithotomy, a Prospective Cross-Sectional Study. Nephro-Urol Mon. 2024;16(4):e148503. doi: https://doi.org/10.5812/numonthly-148503
Haghighi B, Oskuilar H, Nejadi O, Etesam N, Mostafavi H. Comparison of 3-Day and 7-Day Ciprofloxacin Regimen for the Treatment of Uncomplicated Urinary Tract Infection in Women:A Randomized Double-Blind Clinical Trial. Arch Clin Infect Dis. 2010;5(2):. doi:
Khorvash F, Mostafavizadeh K, Mobasherizadeh S, Behjati M, Salehi M. Emergence of Cefepime Resistance in Gram-Negative Induced Nosocomial Infections. Arch Clin Infect Dis. 2009;4(1):. doi:
Fesharakinia A, Ehsanbakhsh A, Ghorashadizadeh N. Ceftriaxone–Associated Nephrolithiasis in Children. Inn J Pediatr. 2013;23(6):. doi:
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):